0001878646-24-000026.txt : 20240919 0001878646-24-000026.hdr.sgml : 20240919 20240919160502 ACCESSION NUMBER: 0001878646-24-000026 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240919 DATE AS OF CHANGE: 20240919 EFFECTIVENESS DATE: 20240919 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Metabolics Pharma, Inc. CENTRAL INDEX KEY: 0002037862 ORGANIZATION NAME: IRS NUMBER: 994642996 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-524521 FILM NUMBER: 241310452 BUSINESS ADDRESS: STREET 1: 2005 MARKET STREET STREET 2: SUITE 3125 CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 215-372-8031 MAIL ADDRESS: STREET 1: 2005 MARKET STREET STREET 2: SUITE 3125 CITY: PHILADELPHIA STATE: PA ZIP: 19103 D 1 primary_doc.xml X0708 D LIVE 0002037862 Metabolics Pharma, Inc. 2005 MARKET STREET SUITE 3125 PHILADELPHIA PA PENNSYLVANIA 19103 215-372-8031 DELAWARE None None Corporation true 2024 Richard Larson 2005 Market Street Suite 3125 Philadelphia PA PENNSYLVANIA 19103 Executive Officer Director Jay A Brammer 2005 Market Street Suite 3125 Philadelphia PA PENNSYLVANIA 19103 Director Mark Finn 2005 Market Street Suite 3125 Philadelphia PA PENNSYLVANIA 19103 Director John Dessouki 2005 Market Street Suite 3125 Philadelphia PA PENNSYLVANIA 19103 Executive Officer Director Mark Kamp 2005 Market Street Suite 3125 Philadelphia PA PENNSYLVANIA 19103 Director Barry Miller 2005 Market Street Suite 3125 Philadelphia PA PENNSYLVANIA 19103 Director Biotechnology Decline to Disclose 06b false 2024-09-05 false true false 0 6299989 5526626 773363 false 7 0 0 0 false Metabolics Pharma, Inc. /s/Richard Larson Richard Larson Chief Executive Officer 2024-09-19